Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability.
Business Model:
Revenue: $4.2M
Employees: 201-500
Address: 733 Concord Avenue
City: Cambridge
State: MA
Zip: 02138
Country: US
Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability.
Contact Phone:
+16179492900
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/11/2015
Ticker Symbol:
WVE
IPO Price:
$16/share
Amount Raised:
$102M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Equity | $11.8M | 11/2015 | IPO | $102M |
|
12/2015 | Equity | 1 | $30M |
Teva Pharmaceutical Industries Teva Pharmaceutical Industries |
2/2015 | Series A | 2 | $18M |
RA Capital Management RA Capital Management SNBL USA RA Capital Management RA Capital Management |
8/2015 | Series B | 7 | $66M |
Fidelity Management and Research Company Foresite Capital Jennison Associates New Leaf Venture Partners Redmile Group Cormorant Asset Management RA Capital Management Foresite Capital Fidelity Management and Research Company Foresite Capital Jennison Associates New Leaf Venture Partners Redmile Group Cormorant Asset Management RA Capital Management Foresite Capital |
12/2022 | Post-IPO Equity | 1 | $50M |
GlaxoSmithKline GlaxoSmithKline |
2/2018 | Post-IPO Equity | 1 | $60M |
Takeda Ventures Takeda Ventures Takeda Ventures Takeda Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|